Back to Search Start Over

Comment on: "Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis".

Authors :
Tsivgoulis G
Palaiodimou L
Katsanos AH
Voumvourakis K
Hadjigeorgiou GM
Heliopoulos I
Karapanayiotides T
Papathanasopoulos P
Kilidireas C
Grigoriadis N
Source :
CNS drugs [CNS Drugs] 2019 Mar; Vol. 33 (3), pp. 293-295.
Publication Year :
2019

Details

Language :
English
ISSN :
1179-1934
Volume :
33
Issue :
3
Database :
MEDLINE
Journal :
CNS drugs
Publication Type :
Report
Accession number :
30806966
Full Text :
https://doi.org/10.1007/s40263-019-00615-5